Celsius (NASDAQ:CELH) Hits New 12-Month High After Strong Earnings

Key Points

• Celsius Holdings Inc. shares hit a new 52-week high of $53.00 after the company reported a stronger than expected earnings per share (EPS) of $0.47, significantly beating the consensus estimate of $0.23.
• Institutional investors hold 60.95% of Celsius's stock, with notable increases in holdings from firms like Alliancebernstein L.P. and FMR LLC during the last quarter.
• The stock is rated as a "Moderate Buy" by analysts, with a consensus price target of $47.83, amid ongoing positive sentiment following the company's performance.

Celsius Holdings Inc. (NASDAQ:CELH - Get Free Report) shares reached a new 52-week high during mid-day trading on Thursday following a stronger than expected earnings report. The company traded as high as $53.00 and last traded at $52.18, with a volume of 2686020 shares trading hands. The stock had previously closed at $42.74.

The company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.24. Celsius had a return on equity of 42.12% and a net margin of 8.40%. During the same period in the prior year, the company earned $0.28 earnings per share. Celsius's revenue was up 83.9% on a year-over-year basis.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on CELH shares. Piper Sandler increased their target price on Celsius from $44.00 to $45.00 and gave the stock an "overweight" rating in a report on Wednesday, June 4th. Citigroup assumed coverage on Celsius in a research note on Wednesday, July 23rd. They set a "buy" rating and a $55.00 price objective on the stock. JPMorgan Chase & Co. lifted their price objective on Celsius from $44.00 to $54.00 and gave the stock an "overweight" rating in a report on Thursday, July 31st. Stifel Nicolaus lifted their target price on Celsius from $47.00 to $50.00 and gave the company a "buy" rating in a report on Tuesday, July 29th. Finally, Truist Financial lifted their price target on Celsius from $50.00 to $55.00 and gave the company a "buy" rating in a research report on Monday, July 14th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and fourteen have given a buy rating to the stock. According to data from MarketBeat, Celsius has a consensus rating of "Moderate Buy" and a consensus price target of $47.83.

Insider Buying and Selling at Celsius

In other Celsius news, major shareholder William H. Milmoe sold 300,000 shares of the stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $47.27, for a total value of $14,181,000.00. Following the transaction, the insider owned 18,017,770 shares of the company's stock, valued at approximately $851,699,987.90. This represents a 1.64% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Deborah Desantis sold 100,000 shares of the stock in a transaction dated Thursday, July 31st. The shares were sold at an average price of $47.50, for a total value of $4,750,000.00. Following the completion of the transaction, the insider directly owned 17,717,770 shares in the company, valued at approximately $841,594,075. This represents a 0.56% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 962,974 shares of company stock valued at $44,658,418. 2.55% of the stock is owned by company insiders.

Institutional Trading of Celsius

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. Alliancebernstein L.P. boosted its holdings in shares of Celsius by 26.3% in the 1st quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company's stock worth $642,769,000 after purchasing an additional 3,753,055 shares during the period. Alyeska Investment Group L.P. lifted its stake in shares of Celsius by 60.5% during the 4th quarter. Alyeska Investment Group L.P. now owns 6,877,918 shares of the company's stock worth $181,164,000 after acquiring an additional 2,591,345 shares during the last quarter. FMR LLC lifted its holdings in shares of Celsius by 64.2% in the 4th quarter. FMR LLC now owns 4,055,148 shares of the company's stock worth $106,813,000 after buying an additional 1,585,839 shares during the period. Champlain Investment Partners LLC purchased a new stake in shares of Celsius in the 4th quarter worth $85,068,000. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its holdings in shares of Celsius by 12.5% in the 4th quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,682,225 shares of the company's stock worth $70,650,000 after buying an additional 298,565 shares during the period. Institutional investors own 60.95% of the company's stock.

Celsius Stock Performance

The firm has a market capitalization of $13.42 billion, a PE ratio of 161.18, a PEG ratio of 1.49 and a beta of 1.40. The company has a fifty day simple moving average of $43.95 and a two-hundred day simple moving average of $35.72.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.